XML 44 R25.htm IDEA: XBRL DOCUMENT v3.22.1
Fair Value Measurements (Tables)
12 Months Ended
Dec. 31, 2021
Fair Value Disclosures [Abstract]  
Schedule of Fair Value Assets and Liabilities

The following table summarizes the assets and liabilities measured at fair value on a recurring basis as of December 31, 2021 and December 31, 2020, by level within the fair value hierarchy:

 

   December 31, 2021 
   (Level 1)   (Level 2)   (Level 3)   Total 
Assets:                    
Marketable securities (certificates of deposit)  $-   $1,255,266   $-   $1,255,266 
Total assets measured at fair value  $-   $1,255,266   $-   $1,255,266 
Liabilities:                    
Contingent consideration - common stock  $           -   $      -   $8,684,669   $8,684,669 
Contingent consideration - warrants   -    -    1,747,972    1,747,972 
Total liabilities measured at fair value  $-   $-   $10,432,641   $10,432,641 

 

   December 31, 2020 
   (Level 1)   (Level 2)   (Level 3)   Total 
Assets:                
Marketable securities (certificates of deposit)  $-   $4,335,446   $             -   $4,335,446 
Total assets measured at fair value  $-   $4,335,446   $-   $4,335,446 
Schedule of Changes in Fair Value Measurement

The changes for Level 3 items measured at fair value on a recurring basis are as follows:

 

Fair value as of December 31, 2020  $- 
Contingent considered issued for business acquisitions   10,432,641 
Fair value as of December 31, 2021  $10,432,641 
Schedule of Contingent Consideration Common Stock and Warrants

 

   December 31, 2021 
Stock price  $8.93 
Strike price  $9.13 
Volatility   80.00%
Risk-free rate   1.30%
Expected term   5.0 

 

 

In order to calculate the probability-adjusted value of the contingent consideration-common stock and contingent consideration-warrants, the Company estimated the probability of achieving certain milestones, which include regulatory approval for identified products, as well as production and net revenue targets. The probability of achieving the milestone related to net revenues was estimated using a Monte Carlo simulation valuation model. The unobservable significant inputs to the valuation model were as follows:

 

   December 31, 2021 
Stock price  $8.93 
Risk-free rate   1.30%
Expected term   5.0 
Weighted-average cost of capital   27.00%
Revenue discount rate   9.50%
Equity volatility   80.00%
Asset volatility   80.00%
Revenue volatility   30.00%